Retatrutide is still in development and is currently not approved for sale on the European market. However, it may already be available through other websites. Using such products could pose serious health risks, as their quality, composition, and safety cannot be assured. We therefore strongly advise against purchasing Retatrutide online.
Doctoronline only provides registered and approved medicines. Retatrutide will only become available following approval based on EMA assessment and once its sale is legally permitted.
Retatrutide is a new treatment for those who are overweight or living with obesity
The medication has not yet received approval or become available
It works by targeting three different receptors at the same time
Clinical trials to date suggest potential weight loss of up to 24%
Side effects seem to be similar to those seen with other GLP-1 medications
